Micro dosing studies done in w hich ph ase of clinical triais-

**Core Concept**
Microdosing studies are a type of clinical trial that involves the administration of very low doses of a new drug to a small number of human subjects. This is done to assess the **pharmacokinetics** and **pharmacodynamics** of the drug. The primary goal is to determine if the drug is safe and effective.

**Why the Correct Answer is Right**
Since the question is incomplete, I will provide general information about microdosing studies. Microdosing studies are typically conducted in the **exploratory phase**, which is also known as **Phase 0**. This phase is designed to speed up the development of promising drugs by establishing very early on if the drug has the desired **pharmacological effect**.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it is not specified, but typically, microdosing is not done in later phases like Phase I, which focuses on safety.
**Option B:** Similarly, this option is incorrect because Phase II focuses on efficacy, not microdosing.
**Option C:** This option might seem plausible, but without the specific option text, we can't say for sure, but microdosing is usually before Phase I.
**Option D:** This option is likely incorrect for the same reason as the others, as microdosing is usually done before these phases.

**Clinical Pearl / High-Yield Fact**
Microdosing studies can significantly reduce the time and cost associated with traditional clinical trials. They also minimize the risk of adverse effects, as only a small dose of the drug is administered.

**Correct Answer:** Correct Answer: B. Phase 0.